The US bioeconomy is worth $950 billion, and growing, thanks to these federal policies

Biotechnology — or the use of technology to convert plant and biological material into commodities — is not new.  Doug Friedman, CEO of BioMADE, the Bioindustrial Manufacturing Innovation Institute, and…

Continue ReadingThe US bioeconomy is worth $950 billion, and growing, thanks to these federal policies